These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 125813)
1. [A contribution to the effects of synthetic progesterone on systemic scleroderma (author's transl)]. Ishikawa H; Tamura T; Horiuchi R; Tuihiji T; Ishii Y Nihon Hifuka Gakkai Zasshi; 1975 Apr; 85(5):299-301. PubMed ID: 125813 [No Abstract] [Full Text] [Related]
2. [Urinary excretion of mucopolysaccharides in patients with collagen diseases (author's transl)]. Kreysel HW; Köhler A Dermatologica; 1974; 148(1):19-27. PubMed ID: 4275497 [No Abstract] [Full Text] [Related]
3. [Gestagens in the treatment of scleroderma]. Szczepański A Przegl Dermatol; 1973; 60(4):521-3. PubMed ID: 4755917 [No Abstract] [Full Text] [Related]
4. [Quantitative isolation of acid mucopolysaccharides from urine in progressive scleroderma (author's transl)]. Kreysel HW; Kraus H; Stuhlsatz HW; Greiling E; Nissen HP; Kimmig J Arch Dermatol Res (1975); 1977 Jul; 259(1):11-9. PubMed ID: 143247 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of sclerodermia diffusa by drugs, with a contribution to the effective mechanism of the drugs (author's transl)]. Ishikawa H; Tamura T; Horiuchi R; Hattori A; Ishii Y Nihon Hifuka Gakkai Zasshi; 1977 Aug; 87(9):555-64. PubMed ID: 303300 [No Abstract] [Full Text] [Related]
7. [Glycosaminoglucuronates and their fractions in the urine of patients with scleroderma]. Kowalczyk J; Oszewska Z Przegl Dermatol; 1978; 65(5):527-33. PubMed ID: 725096 [No Abstract] [Full Text] [Related]
8. [Theoretical aspects of the new possibilities of use of hyaluronidase]. Petter O; Bellmann H Z Gesamte Inn Med; 1971 Mar; 26(5):171-4. PubMed ID: 5560774 [No Abstract] [Full Text] [Related]
10. [Therapy of scleroderma with griseofulvin (author's transl)]. Kobíková M; Stáva Z; Cerná M Cesk Dermatol; 1976 Aug; 51(4):224-6. PubMed ID: 788928 [No Abstract] [Full Text] [Related]
11. [On some essential differences of scleroderma, dermatomyositis and acute lupus erythematosus and the variegated therapy based on them]. Korting GW Dtsch Med Wochenschr; 1967 Feb; 92(7):281-8. PubMed ID: 6019059 [No Abstract] [Full Text] [Related]
13. An approach to experimental scleroderma, using urinary glycosaminoglycans from patients with systemic scleroderma. Ishikawa H; Suzuki S; Horiuchi R; Sato H Acta Derm Venereol; 1975; 55(2):97-107. PubMed ID: 48324 [TBL] [Abstract][Full Text] [Related]
14. Scleroderma and urinary excretion of acidic glycosaminoglycans. Hardy KH; Rosevear JW; Sams WM; Winkelmann RK Mayo Clin Proc; 1971 Feb; 46(2):119-27. PubMed ID: 4251060 [No Abstract] [Full Text] [Related]
15. [On the modification of serum and urinary mucopolysaccharides of patients with scleroderma using gestagen therapy]. Holzmann H; Korting GW; Morsches B Arch Klin Exp Dermatol; 1968; 231(2):156-60. PubMed ID: 4233426 [No Abstract] [Full Text] [Related]